Protara Therapeutics Inc (TARA)
R&D Expense Growth
25.85%
Quarterly · Period ending:
TARA R&D Expense Growth
Latest reported25.85%period ending
Latest reported25.85%period ending
TARA Quarterly R&D Growth (QoQ) (0.00% → 25.85%)
Latest values, visible window
High-resolution chart · PNG
TARA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 25.8536% | |
| 2.6516% | |
| 36.8366% | |
| -10.9471% | |
| 17.7307% | |
| -3.6951% | |
| 17.7076% | |
| 26.3504% | |
| -16.6732% | |
| 20.1222% | |
| 2.6214% | |
| -14.199% | |
| 40.91% | |
| 3.0868% | |
| 43.9411% | |
| 12.3865% | |
| -41.469% | |
| 29.5231% | |
| -0.6108% | |
| -30.4739% | |
| -16.3778% | |
| 92.8095% | |
| 30.5892% | |
| 13.2112% | |
| -19.4219% | |
| 196.2323% | |
| -389.91% | |
| 11.3408% | |
| -8.4548% | |
| -2.8147% | |
| -52.886% | |
| -14.7101% | |
| -32.1867% | |
| 26.7913% | |
| -68.9555% | |
| 165.8098% | |
| -8.4706% | |
| -4.2793% | |
| -8.2645% | |
| -7.6336% | |
| 20.4598% | |
| 21.5084% | |
| 16.2338% | |
| -0.3236% | |
| 17.4905% | |
| 40.6417% | |
| 5.471% | |
| 0% |